Organigram Global (OGI) Other financing activities (2018 - 2026)
Organigram Global (OGI) posted quarterly Other financing activities of -$328.9 million for Q1 2026, down 101.16% year-over-year from $28.3 billion in Q1 2025, and down 7643805.15% quarter-over-quarter from $4302.5 in Q4 2025.
Organigram Global (OGI) Other financing activities (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Other financing activities for 7 consecutive years, with -$328.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities fell 101.16% year-over-year to -$328.9 million; the TTM figure through Mar 2026 stood at $28.0 billion (down 81.58% YoY), while the FY2021 annual figure was $17000.0, changed N/A from the prior year.
- Other financing activities declined to -$328.9 million in Q1 2026 per OGI's latest filing, from $4302.5 in the prior quarter.
- Across five years, Other financing activities topped out at $28.3 billion in Q1 2025 and bottomed at -$328.9 million in Q1 2026.
- Historically, Other financing activities has averaged $7.0 billion across 3 years, with a median of $2079.0 in 2024.
- Annual changes were most pronounced in 2025 — Other financing activities surged 3075.43% — and 2026, when it sank 101.16%.
- Organigram Global's Other financing activities stood at -$144.6 in 2024, then soared by 3075.43% to $4302.5 in 2025, then sank by 7643805.15% to -$328.9 million in 2026.
- Business Quant data shows OGI's Other financing activities at -$328.9 million in Q1 2026, $4302.5 in Q4 2025, and $28.3 billion in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Organigram Global | 150.66 Mn | 150.54 Mn | 28.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -328.87 Mn |
| Mar 31, 2026 | -328.87 Mn |
| Dec 31, 2025 | 4,302.52 |
| Dec 31, 2025 | 4,302.52 |
| Mar 31, 2025 | 28.34 Bn |
| Mar 31, 2025 | 28.34 Bn |
| Dec 31, 2024 | -144.60 |
| Dec 31, 2024 | -144.60 |
| May 31, 2021 | 174.41 Bn |
| May 31, 2021 | 174.41 Bn |
| Feb 28, 2021 | -50.72 Bn |
| Feb 28, 2021 | -50.72 Bn |
| Nov 30, 2020 | 63.19 Bn |
| Nov 30, 2020 | 63.19 Bn |
| May 31, 2020 | 27,697.00 |
| May 31, 2020 | 27,697.00 |
| Feb 29, 2020 | 873,971.00 |
| Feb 29, 2020 | 873,971.00 |
| Aug 31, 2019 | 8,572.00 |
| Aug 31, 2019 | 8,572.00 |